Longtime Teva CFO Desheh could be next out the struggling drugmaker's door | Fierce Pharma
Teva Seeks New CFO as It Faces High Debt Levels, Opioid Litigation - WSJ
New Teva CEO shakes up structure and leadership at troubled drugmaker | The Times of Israel
From left, Dan S. Suesskind, CFO, Shlomo Yanai, incoming president and CEO, Israel Makov, outgoing president and CEO, and Eli Hurvitz, chairman of the board of Teva Pharmaceutical Industries, Ltd. take part
Teva says CFO Michael McClellan will step down | Careers | POST Online Media
High Debt, Potential Litigation Costs Face New Teva CFO - WSJ
Teva scouts new CFO as McClellan steps down for personal reasons | Fierce Pharma
Teva's new CEO shakes up management, to combine divisions | Reuters
From left, Dan S. Suesskind, CFO, Shlomo Yanai, incoming president and CEO, Israel Makov, outgoing president and CEO, and Eli Hurvitz, chairman of the board of Teva Pharmaceutical Industries, Ltd. take part
Chutes & Ladders—Teva's longtime CFO to step down | Fierce Biotech
drug prices Archives - www.israelhayom.com
Teva Pharmaceuticals (@TevaUSA) / Twitter
New Teva CEO shakes up structure and executive ranks as major layoffs loom | Fierce Pharma